Managing Member of General Partner
Dr. Couture’s recognized
expertise, established over
nearly three decades of work
with experimental biologics,
and heavily focused on cell
and gene therapies, includes
manufacturing and clinical
• Key participant in numerous first-in-man clinical studies, including first human gene therapy trials, first direct administration to humans of a genetically engineered virus, and many other cell and gene therapy firsts.
• 18 years with City of Hope National Medical Center, where he was the Founding Director and Senior Vice President of the Center for Applied Technology (CAT).
• Officer and/or director of the following Fund portfolio companies: Chief Executive Officer of Arrogene, Inc. and Orbsen Therapeutics, Ltd., President of Vault Nano Inc. dba Vault Pharma, Chief Operating Officer of Westwood Bioscience, Inc., Chief Scientific Officer of LongLifeRx, Inc., member of the board of directors of Arrogene, Inc., LongLifeRx, Inc., Orbsen Therapeutics, Ltd., Vault Nano Inc. dba Vault Pharma and Westwood Bioscience, Inc.